Filters

CDC34 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

CDC34 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) size: 1.0 µg DNA 322

Price 322
Size 1.0 µg DNA
DNA lentivector for transduction information GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions, Vectors with selection markers like kanamycin, our 3rd Generation Packaging mixture, pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C, puromycin or cumate are available, Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Gene targetCDC34 Lentiviral Vector (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
Short nameCDC34 Lentiviral Vector ( ) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
TechniqueVectors
Species Humans, Human
Alternative name sapiens) (cytomegalovirus) (pLenti-GIII-cytomegalovirus-Green Fluorescent-2A-Puro), CDC34 Lentiviral integrating Desoxyribonucleic acid sequence (H
Identity 1734
Gene CDC34
Long gene name cell division cycle 34
Synonyms gene name cell division cycle 34 cell division cycle 34 homolog (S, cerevisiae)
Synonyms E2-CDC34 UBE2R1 UBC3
Synonyms name ubiquitin conjugating enzyme E2 R1
Locus 19p13, 3
Discovery year 1994-05-12
GenBank acession L22005
Entrez gene record 997
Pubmed identfication 8248134 16210246
RefSeq identity NM_004359
Classification Ubiquitin conjugating enzymes E2
Havana BLAST/BLAT OTTHUMG00000180558

Subscribe to our Newsletter